Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3
Authors
Keywords
-
Journal
ONCOGENE
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-04-30
DOI
10.1038/s41388-018-0276-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatments for EGFR-mutant non-small cell lung cancer (NSCLC): The road to a success, paved with failures
- (2017) Dae Ho Lee PHARMACOLOGY & THERAPEUTICS
- EMT: 2016
- (2016) M. Angela Nieto et al. CELL
- Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR- Activating Mutation
- (2016) Silvia La Monica et al. Journal of Thoracic Oncology
- miRNA Deregulation in Cancer Cells and the Tumor Microenvironment
- (2016) R. Rupaimoole et al. Cancer Discovery
- International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
- (2015) H. Dombret et al. BLOOD
- Combinatorial Action of MicroRNAslet-7and miR-34 Effectively Synergizes with Erlotinib to Suppress Non-small Cell Lung Cancer Cell Proliferation
- (2015) Carlos Stahlhut et al. CELL CYCLE
- Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance
- (2015) Laetitia Seguin et al. TRENDS IN CELL BIOLOGY
- Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma
- (2015) Cuiping Wang et al. TUMOR BIOLOGY
- MicroRNA-34a overcomes HGF-mediated gefitinib resistance in EGFR mutant lung cancer cells partly by targeting MET
- (2014) Jian-Ya Zhou et al. CANCER LETTERS
- Aberrant Regulation and Function of MicroRNAs in Cancer
- (2014) Brian D. Adams et al. CURRENT BIOLOGY
- Targeting FAK in human cancer: from finding to first clinical trials
- (2014) Vita Golubovskaya Frontiers in Bioscience-Landmark
- An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition
- (2014) Laetitia Seguin et al. NATURE CELL BIOLOGY
- Acquired Resistance to EGFR Inhibitors Is Associated with a Manifestation of Stem Cell-like Properties in Cancer Cells
- (2013) K. Shien et al. CANCER RESEARCH
- Erlotinib Resistance in Lung Cancer Cells Mediated by Integrin 1/Src/Akt-Driven Bypass Signaling
- (2013) R. Kanda et al. CANCER RESEARCH
- Lower gefitinib dose led to earlier resistance acquisition before emergence of T790M mutation in epidermal growth factor receptor-mutated lung cancer model
- (2013) Hiromi Hayakawa et al. CANCER SCIENCE
- Tumor suppressor function of miR-483-3p on squamous cell carcinomas due to its pro-apoptotic properties
- (2013) Thomas BERTERO et al. CELL CYCLE
- Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers
- (2013) H. A. Yu et al. CLINICAL CANCER RESEARCH
- MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer
- (2013) Bing Li et al. LUNG CANCER
- MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma
- (2012) Wen Wang et al. CARCINOGENESIS
- An Epithelial-Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance
- (2012) L. A. Byers et al. CLINICAL CANCER RESEARCH
- Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
- (2012) Zhenfeng Zhang et al. NATURE GENETICS
- MiR-663, a microRNA targeting p21 WAF1/CIP1 , promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma
- (2012) C Yi et al. ONCOGENE
- Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma
- (2012) Wen Wang WORLD JOURNAL OF GASTROENTEROLOGY
- The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma
- (2011) Deniz M Özata et al. ENDOCRINE-RELATED CANCER
- Epithelial to Mesenchymal Transition in an Epidermal Growth Factor Receptor-Mutant Lung Cancer Cell Line with Acquired Resistance to Erlotinib
- (2011) Kenichi Suda et al. Journal of Thoracic Oncology
- Inflammation-induced repression of tumor suppressor miR-7 in gastric tumor cells
- (2011) D Kong et al. ONCOGENE
- Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
- (2011) L. V. Sequist et al. Science Translational Medicine
- The role of the miR-200 family in epithelial-mesenchymal transition
- (2010) Perry S. Mongroo et al. CANCER BIOLOGY & THERAPY
- Loss of PTEN Expression by Blocking Nuclear Translocation of EGR1 in Gefitinib-Resistant Lung Cancer Cells Harboring Epidermal Growth Factor Receptor-Activating Mutations
- (2010) C. Yamamoto et al. CANCER RESEARCH
- Oncogenic Role of miR-483-3p at the IGF2/483 Locus
- (2010) A. Veronese et al. CANCER RESEARCH
- Regulation of Insulin-like Growth Factor–Mammalian Target of Rapamycin Signaling by MicroRNA in Childhood Adrenocortical Tumors
- (2010) Mabrouka Doghman et al. CANCER RESEARCH
- MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer
- (2010) Jun Hao et al. FEBS LETTERS
- Integrin beta1 over-expression associates with resistance to tyrosine kinase inhibitor gefitinib in non-small cell lung cancer
- (2010) Lixia Ju et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors
- (2010) Xi Liu et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical and molecular evidences of epithelial to mesenchymal transition in acquired resistance to EGFR-TKIs
- (2010) Jin-Haeng Chung et al. LUNG CANCER
- Resistance May Not Be Futile: microRNA Biomarkers for Chemoresistance and Potential Therapeutics
- (2010) K. E. Allen et al. MOLECULAR CANCER THERAPEUTICS
- RETRACTED: A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis
- (2009) Scott Valastyan et al. CELL
- CDKN2A,NF2, andJUNare dysregulated among other genes by miRNAs in malignant mesothelioma-A miRNA microarray analysis
- (2009) Mohamed Guled et al. GENES CHROMOSOMES & CANCER
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
- (2009) Pierre Fenaux et al. LANCET ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now